U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07427719) titled 'Retinopathy of Prematurity - Visual Function and Retinal Structure' on Jan. 19.
Brief Summary: Children born prematurely may develop a characteristic retinal disease named retinopathy of prematurity (ROP). This disease could lead to retinal detachment and blindness. ROP was traditionally treated with laser, but injection with a medication (A-VEGF) has become more common.
In this study, the researchers will explore whether treatment of ROP affects visual function and retinal development. To explore this, the study group will examine children with ROP (but not treated) with children treated with either laser or injection. The researc...